TY - JOUR
T1 - ENU-mutagenesis mice with a non-synonymous mutation in Grin1 exhibit abnormal anxiety-like behaviors, impaired fear memory, and decreased acoustic startle response
AU - Umemori, Juzoh
AU - Takao, Keizo
AU - Koshimizu, Hisatsugu
AU - Hattori, Satoko
AU - Furuse, Tamio
AU - Wakana, Shigeharu
AU - Miyakawa, Tsuyoshi
N1 - Funding Information:
We thank all members of the division of Systems Medical Science at Fujita Health University for rearing the mice and supporting this study. This research was supported by Grant-in-Aid for Scientific Research on Priority Areas (200163013), Grant-in-Aid for Exploratory Research (19653081), Grant-in-Aid for Scientific Research (B) (21300121), Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, a grant from the Neuroinformatics Japan Center (NIJC), and grants from Core Research for Evolutional Science and Technology (CREST) and the Institute for Bioinformatics Research and Development (BIRD) of the Japan Science and Technology Agency (JST).
PY - 2013
Y1 - 2013
N2 - Background: The Grin1 (glutamate receptor, ionotropic, NMDA1) gene expresses a subunit of N-methyl-D-aspartate (NMDA) receptors that is considered to play an important role in excitatory neurotransmission, synaptic plasticity, and brain development. Grin1 is a candidate susceptibility gene for neuropsychiatric disorders, including schizophrenia, bipolar disorder, and attention deficit/hyperactivity disorder (ADHD). In our previous study, we examined an N-ethyl-N-nitrosourea (ENU)-generated mutant mouse strain (Grin1 Rgsc174/Grin1 +) that has a non-synonymous mutation in Grin1. These mutant mice showed hyperactivity, increased novelty-seeking to objects, and abnormal social interactions. Therefore, Grin1 Rgsc174/ Grin1 + mice may serve as a potential animal model of neuropsychiatric disorders. However, other behavioral characteristics related to these disorders, such as working memory function and sensorimotor gating, have not been fully explored in these mutant mice. In this study, to further investigate the behavioral phenotypes of Grin1 Rgsc174/Grin1 + mice, we subjected them to a comprehensive battery of behavioral tests. Results: There was no significant difference in nociception between Grin1 Rgsc174/Grin1 + and wild-type mice. The mutants did not display any abnormalities in the Porsolt forced swim and tail suspension tests. We confirmed the previous observations that the locomotor activity of these mutant mice increased in the open field and home cage activity tests. They displayed abnormal anxiety-like behaviors in the light/dark transition and the elevated plus maze tests. Both contextual and cued fear memory were severely deficient in the fear conditioning test. The mutant mice exhibited slightly impaired working memory in the eight-arm radial maze test. The startle amplitude was markedly decreased in Grin1 Rgsc174/Grin1 + mice, whereas no significant differences between genotypes were detected in the prepulse inhibition (PPI) test. The mutant mice showed no obvious deficits in social behaviors in three different social interaction tests. Conclusions: This study demonstrated that the Grin1 Rgsc174/Grin1 + mutation causes abnormal anxiety-like behaviors, a deficiency in fear memory, and a decreased startle amplitude in mice. Although Grin1 Rgsc174/Grin1 + mice only partially recapitulate symptoms of patients with ADHD, schizophrenia, and bipolar disorder, they may serve as a unique animal model of a certain subpopulation of patients with these disorders.
AB - Background: The Grin1 (glutamate receptor, ionotropic, NMDA1) gene expresses a subunit of N-methyl-D-aspartate (NMDA) receptors that is considered to play an important role in excitatory neurotransmission, synaptic plasticity, and brain development. Grin1 is a candidate susceptibility gene for neuropsychiatric disorders, including schizophrenia, bipolar disorder, and attention deficit/hyperactivity disorder (ADHD). In our previous study, we examined an N-ethyl-N-nitrosourea (ENU)-generated mutant mouse strain (Grin1 Rgsc174/Grin1 +) that has a non-synonymous mutation in Grin1. These mutant mice showed hyperactivity, increased novelty-seeking to objects, and abnormal social interactions. Therefore, Grin1 Rgsc174/ Grin1 + mice may serve as a potential animal model of neuropsychiatric disorders. However, other behavioral characteristics related to these disorders, such as working memory function and sensorimotor gating, have not been fully explored in these mutant mice. In this study, to further investigate the behavioral phenotypes of Grin1 Rgsc174/Grin1 + mice, we subjected them to a comprehensive battery of behavioral tests. Results: There was no significant difference in nociception between Grin1 Rgsc174/Grin1 + and wild-type mice. The mutants did not display any abnormalities in the Porsolt forced swim and tail suspension tests. We confirmed the previous observations that the locomotor activity of these mutant mice increased in the open field and home cage activity tests. They displayed abnormal anxiety-like behaviors in the light/dark transition and the elevated plus maze tests. Both contextual and cued fear memory were severely deficient in the fear conditioning test. The mutant mice exhibited slightly impaired working memory in the eight-arm radial maze test. The startle amplitude was markedly decreased in Grin1 Rgsc174/Grin1 + mice, whereas no significant differences between genotypes were detected in the prepulse inhibition (PPI) test. The mutant mice showed no obvious deficits in social behaviors in three different social interaction tests. Conclusions: This study demonstrated that the Grin1 Rgsc174/Grin1 + mutation causes abnormal anxiety-like behaviors, a deficiency in fear memory, and a decreased startle amplitude in mice. Although Grin1 Rgsc174/Grin1 + mice only partially recapitulate symptoms of patients with ADHD, schizophrenia, and bipolar disorder, they may serve as a unique animal model of a certain subpopulation of patients with these disorders.
KW - ADHD
KW - Comprehensive behavioral test battery
KW - ENU-mutagenesis
KW - Grin1
KW - NMDA receptor
KW - Psychiatric disorder
KW - Schizophrenia
UR - http://www.scopus.com/inward/record.url?scp=84877888175&partnerID=8YFLogxK
U2 - 10.1186/1756-0500-6-203
DO - 10.1186/1756-0500-6-203
M3 - 学術論文
C2 - 23688147
AN - SCOPUS:84877888175
SN - 1756-0500
VL - 6
JO - BMC Research Notes
JF - BMC Research Notes
IS - 1
M1 - 203
ER -